Poly Medicure Limited has announced a board meeting to discuss the Monitoring Agency Report concerning the utilization of proceeds from their Qualified Institutional Placement (QIP) for the quarter ended September 30, 2024. The QIP raised approximately ₹999.99 crores, with net proceeds of about ₹984.99 crores. According to the report by CRISIL Ratings, the company has utilized ₹84.99 crores for general corporate purposes, primarily working capital, indicating a strategic focus on operational liquidity. The lack of deviations from planned expenditures reflects sound management practices, potentially leading to a positive outlook among investors as the company continues to advance its growth initiatives in the medical equipment sector.